New York State Common Retirement Fund Dynavax Technologies Corp Transaction History

New York State Common Retirement Fund

  • $75.2 Billion
  • Q2 2025

A detailed history of New York State Common Retirement Fund transactions in Dynavax Technologies Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 24,893 shares of DVAX stock, worth $258,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,893
Previous 34,993 28.86%
Holding current value
$258,887
Previous $454,000 45.59%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Oct 08, 2025
SELL
$9.4 - $12.87 $94,940 - $129,986
-10,100 Reduced 28.86%
24,893 $246,000
Q2 2025

Aug 13, 2025
SELL
$9.4 - $12.87 $94,940 - $129,986
-10,100 Reduced 28.86%
24,893 $247,000
Q1 2025

Oct 08, 2025
BUY
$12.39 - $14.4 $6,195 - $7,200
500 Added 1.45%
34,993 $453,000
Q1 2025

May 01, 2025
BUY
$12.39 - $14.4 $6,195 - $7,200
500 Added 1.45%
34,993 $454,000
Q3 2024

Oct 08, 2025
BUY
$10.05 - $11.61 $96,480 - $111,456
9,600 Added 38.57%
34,493 $384,000
Q3 2024

Oct 28, 2024
SELL
$10.05 - $11.61 $182,910 - $211,302
-18,200 Reduced 34.54%
34,493 $384,000
Q2 2024

Oct 08, 2025
BUY
$10.73 - $12.58 $298,294 - $349,724
27,800 Added 111.68%
52,693 $591,000
Q2 2024

Jul 31, 2024
BUY
$10.73 - $12.58 $826 - $968
77 Added 0.15%
52,693 $592,000
Q1 2024

Oct 08, 2025
BUY
$11.7 - $14.98 $324,359 - $415,290
27,723 Added 111.37%
52,616 $652,000
Q1 2024

May 07, 2024
SELL
$11.7 - $14.98 $1,275 - $1,632
-109 Reduced 0.21%
52,616 $653,000
Q4 2023

Oct 08, 2025
BUY
$13.09 - $14.98 $364,320 - $416,923
27,832 Added 111.81%
52,725 $737,000
Q4 2023

Feb 01, 2024
BUY
$13.09 - $14.98 $37,437 - $42,842
2,860 Added 5.74%
52,725 $737,000
Q3 2023

Oct 08, 2025
BUY
$12.64 - $14.99 $315,646 - $374,330
24,972 Added 100.32%
49,865 $736,000
Q3 2023

Nov 07, 2023
SELL
$12.64 - $14.99 $302,993 - $359,325
-23,971 Reduced 32.47%
49,865 $737,000
Q2 2023

Oct 08, 2025
BUY
$9.85 - $13.17 $482,088 - $644,579
48,943 Added 196.61%
73,836 $953,000
Q2 2023

Aug 07, 2023
BUY
$9.85 - $13.17 $66,546 - $88,976
6,756 Added 10.07%
73,836 $954,000
Q1 2023

Oct 08, 2025
SELL
$9.44 - $11.88 $643,855 - $810,275
-68,205 Reduced 50.42%
67,080 $658,000
Q1 2023

May 02, 2023
SELL
$9.44 - $11.88 $643,855 - $810,275
-68,205 Reduced 50.42%
67,080 $658,000
Q4 2022

Oct 08, 2025
BUY
$10.27 - $13.29 $1.13 Million - $1.47 Million
110,392 Added 443.47%
135,285 $1.44 Million
Q4 2022

Jan 30, 2023
BUY
$10.27 - $13.29 $516,457 - $668,327
50,288 Added 59.16%
135,285 $1.44 Million
Q3 2022

Nov 08, 2022
BUY
$9.93 - $17.44 $73,779 - $129,579
7,430 Added 9.58%
84,997 $887,000
Q2 2022

Aug 04, 2022
SELL
$7.45 - $12.83 $47,970 - $82,612
-6,439 Reduced 7.66%
77,567 $977,000
Q1 2022

May 05, 2022
BUY
$9.75 - $14.44 $1,121 - $1,660
115 Added 0.14%
84,006 $911,000
Q4 2021

Feb 02, 2022
SELL
$13.17 - $20.94 $3,727 - $5,926
-283 Reduced 0.34%
83,891 $1.18 Million
Q3 2021

Nov 02, 2021
SELL
$9.16 - $19.83 $163,304 - $353,529
-17,828 Reduced 17.48%
84,174 $1.62 Million
Q2 2021

Aug 02, 2021
BUY
$7.25 - $10.99 $94,989 - $143,990
13,102 Added 14.74%
102,002 $1.01 Million
Q1 2021

May 11, 2021
BUY
$4.57 - $11.18 $31,990 - $78,260
7,000 Added 8.55%
88,900 $874,000
Q2 2020

Aug 07, 2020
BUY
$2.94 - $9.1 $37,632 - $116,480
12,800 Added 18.52%
81,900 $726,000
Q3 2019

Nov 07, 2019
BUY
$2.69 - $4.85 $47,882 - $86,330
17,800 Added 34.7%
69,100 $247,000
Q2 2019

Aug 09, 2019
SELL
$3.65 - $7.89 $52,560 - $113,616
-14,400 Reduced 21.92%
51,300 $205,000
Q1 2018

May 10, 2018
BUY
$14.65 - $19.9 $93,760 - $127,359
6,400 Added 10.79%
65,700 $1.3 Million
Q4 2017

Feb 13, 2018
BUY
$17.3 - $24.08 $119,370 - $166,152
6,900 Added 13.17%
59,300 $1.11 Million
Q2 2017

Aug 11, 2017
BUY
N/A
52,400
52,400 $506,000

Others Institutions Holding DVAX

# of Institutions
293
Shares Held
120M
Call Options Held
294K
Put Options Held
86.1K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email